What is the Role of Enlarged Lymph Node Resection Alone in Patients With Nonseminomatous Germ Cell Tumor Who Had Stage II or III Disease?

• Published in: Clinical genitourinary cancer Vol. 10; no. 3; pp. 185 - 189
• Main Authors: Ekenel, Meltem, Keskin, Serkan, Şanli, Öner, Bavbek, Sevil, Tunç, Murat, Ander, Haluk, Özcan, Faruk, Kiliçaslan, Işin, Başaran, Mert
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.09.2012
• Subjects: Adolescent; Adult; Combined Modality Therapy; Germ cell tumor; Hematology, Oncology and Palliative Medicine; Humans; Kaplan-Meier Estimate; Lymph Node Excision; Lymph Nodes - pathology; Lymph Nodes - surgery; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal - drug therapy; Neoplasms, Germ Cell and Embryonal - mortality; Neoplasms, Germ Cell and Embryonal - secondary; Neoplasms, Germ Cell and Embryonal - surgery; Orchiectomy; Organ Size; Resection; Retrograde ejaculation; Retroperitoneal masses; Retroperitoneal Space - surgery; Retrospective Studies; Survival; Testicular Neoplasms - drug therapy; Testicular Neoplasms - mortality; Testicular Neoplasms - pathology; Testicular Neoplasms - surgery; Treatment Outcome; Urology; Young Adult; Germ cell tumor; Resection; Retrograde ejaculation; Survival; Retroperitoneal masses
• ISSN: 1558-7673; 1938-0682
• DOI: 10.1016/j.clgc.2012.04.002

Micro-Abstract Retroperitoneal lymph node dissection has been accepted as standard of care for the management of patients with metastatic nonseminomatous germ cell tumors. However, our results suggest that, in patients with metastatic nonseminomatous germ cell tumors of the testis, resection of residual retroperitoneal masses alone is a safe alternative to a difficult, potentially morbid bilateral dissection.